Carregant...
Infliximab’s influence on anastomotic strength and degree of inflammation in intestinal surgery in a rabbit model
BACKGROUND: Infliximab, a TNF-α inhibitor, is a potent anti-inflammatory drug in the treatment of inflammatory bowel diseases. Recent studies have investigated the effect of infliximab treatment on postoperative complications such as anastomotic leakage, however, with conflicting results and conclus...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4017771/ https://ncbi.nlm.nih.gov/pubmed/24762063 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2482-14-23 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|